MA-SKILLSOFT
9.5.2017 15:54:12 CEST | Business Wire | Press release
Skillsoft , the global leader in eLearning and Talent Management, today announced it has appointed Larry Neal as Chief Executive Officer of the group. Bill Donoghue, current CEO, becomes Executive Chairman.
Most recently, Larry has led businesses for S&P Global, formerly McGraw-Hill Financial. As President of S&P Platts, he drove outstanding growth, nearly tripling revenues in seven years. Platts has customers in 170 countries, 60% of revenues outside of North America, and over 1,000 staff across 15 global locations. Prior to Platts, he led significant performance improvements at both the S&P Equity Research and S&P Index Services businesses.
Earlier in his career, Larry led several product, sales and marketing organizations and has extensive sales leadership experience. He started his career at General Electric and IBM, then moving in to sales and business leadership positions at technology-enabled content companies Advent Software, ADP and McGraw-Hill.
“Larry is an outstanding and experienced executive, having repeatedly delivered exceptional P&L performance for five companies. He has a reputation for bringing a unique blend of strategic insight with operational excellence and a relentless customer focus,” said Bill Donoghue, Executive Chairman of the Skillsoft Group. “I am thrilled Larry is joining us and confident he will make an excellent long-term CEO.”
Mr. Neal said: “I am delighted to be joining Skillsoft following the transformation of the group to a digital technology company. It is a world leader in online learning and talent management, with a huge and diverse portfolio of great clients, and committed, dedicated teams across the world. I am looking forward to working with the team through the next phase of the company’s development.”
Frank van den Bosch, Partner at Charterhouse Capital Partners, owners of Skillsoft, said: “Bill Donoghue stepped into the CEO role to lead the company through a huge transformation over the past 15 months, which has now been successfully completed. That transformation of Skillsoft into a digital technology company prepared the ground for a new long-term CEO and we are excited Larry is joining us. Larry brings a track record of growth experience, and is an exceptional operator and leader, whilst Bill will provide continuity and strategic guidance to the team as Executive Chairman.”
About Skillsoft
Skillsoft is the global leader in eLearning,
providing the most engaging learner experience and high-quality content.
We are trusted by the world's leading organizations, including 65
percent of the Fortune 500. Our mission is to build beautiful technology
and engaging content that drives business impact for today’s modern
enterprise. Our 150,000+ multi-modal courses, videos, books and
micro-learning modules are accessed more than 130 million times every
month, in 160 countries and 29 languages. With 100% secure cloud access,
from any device, whenever, wherever. www.skillsoft.com
About SumTotal Systems
SumTotal Systems, LLC, a Skillsoft
Company, is the world’s only unified Human Capital Management Solution.
SumTotal’s award-winning Talent Management Suite enables companies to
attract, know, mobilize, develop, progress and reward their workforce.
SumTotal is continuously innovating to best meet the market challenges
of attracting, retaining, developing and engaging the multi-generational
workforce. The Talent Expansion Suite includes three key components
–Talent, Learn and Work. www.sumtotalsystems.com
About Charterhouse Capital Partners
Charterhouse is one of
the longest established private equity firms operating in Europe. The
firm invests in companies headquartered in Western Europe and works
closely with incumbent management teams, backing them and providing
active support to drive growth. Charterhouse pursues a highly selective
investment approach, partnering with a small number of high-quality
companies. Transaction values range from €250mn to €2bn. Charterhouse is
based in London and has a deep bench of experienced investment
professionals. Since inception Charterhouse has completed over 140
transactions worth an aggregate value of over €50bn. www.charterhouse.co.uk
View source version on businesswire.com: http://www.businesswire.com/news/home/20170509006046/en/
Contact:
Skillsoft
Tara O’Sullivan, +353871771529
Chief Creative Officer
tara.osullivan@skillsoft.com
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed
BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release
Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom